Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

Résumé fourni par la source

In the study, the authors use gene expression data and clinical response from patients enrolled in the TONIC trial (NCT02499367). The TONIC trial is a two-stage trial. While the stage 2 is still ongoing, results of the first stage were previously reported [ https://doi.org/10.1038/s41591-019-0432-4 ] and gene expression data are available on the European Genome-phenome Archive (EGA) under accession number EGAS00001003535 .

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.